<--GAT-->

Research Suggests Gout Drug Could Lower Diabetes Risk Among Veterans

by U.S. Medicine

December 6, 2015

NEW ORLEANS — Could a common drug used for gout lower the risk of diabetes?

That’s what a recent study in the journal Clinical Therapeutics endeavored to find out.1

The study team led by Tulane University researchers conducted a retrospective study of 27,876 adults with gout identified via the Veterans Integrated Services Network 16 data warehouse.

Patients in the study had up to 11 years of follow-up, from January 1999 through December 2010, and the final study sample consisted of 1,046 pairs of 1:1 propensity score-matched patients from the colchicine treated and control cohorts. The researchers’ focus was on time to first diabetes development since the first gout diagnosis was modeled.

Results indicate that, among the matched pairs, 234 veterans who had taken colchicine and 224 veterans who had never taken colchicine developed diabetes; the incidence rates were 38.95 and 39.02 per 1000 patient-years, respectively.

In Poisson and Cox proportional hazards regression, however, the risk of incident diabetes was reduced with increased duration of colchicine use, although the difference was not statistically significant. In further analysis, hazard ratio for incident diabetes among patients who had taken colchicine was 0.877 compared with those who had not taken colchicine.

“This study suggests a possible duration- or dose-related association between colchicine use and reduced risk of diabetes in adults with gout even though the risk reduction was not significant,” according to the study authors, who called for further studies to confirm their findings.

1 Wang L, Sawhney M, Zhao Y, Carpio GR, Fonseca V, Shi L. Association Between Colchicine and Risk of Diabetes Among the Veterans Affairs Population With Gout. Clin Ther. 2015 Jun 1;37(6):1206-15. doi: 10.1016/j.clinthera.2015.03.010. Epub 2015 Apr 7. PubMed PMID: 25857595.


Comments are closed here.


Related Articles

Metformin Halves All-Cause Mortality in Frail Older Veterans

Other Important VA Studies at the American Diabetes Association 79th Scientific Sessions MIAMI—The first-line drug of choice for Type 2 diabetes, metformin has long been known to effectively reduce blood glucose levels and substantially cut... View Article

HIV Patients Had Lower PC Incidence in VA Study

NEW YORK—Non-AIDS defining cancers are increasingly important contributors to health outcomes for aging persons with HIV (PWH), according to a recent conference presentation which also pointed out that, although prostate cancer is prevalent in aging... View Article


U.S. Medicine Recommends


More From diabetes

Diabetes

Metformin Halves All-Cause Mortality in Frail Older Veterans

Other Important VA Studies at the American Diabetes Association 79th Scientific Sessions MIAMI—The first-line drug of choice for Type 2 diabetes, metformin has long been known to effectively reduce blood glucose levels and substantially cut... View Article

Diabetes

Greatest VA Weight Gains in Women Veterans Without Diabetes

ATLANTA—How does a diagnosis of diabetes affect weight management among U.S. veterans? A study in the journal Obesity (Silver Spring) sought to assess weight trends and diabetes prevalence among U.S. veterans.1 Atlanta VAMC researchers and... View Article

Diabetes

Diabetes Patients Do Well in Military Healthcare-to-VA Transition

SAN DIEGO—When service members leave active duty and receive healthcare in a different setting, care for conditions such as diabetes can suffer. A study in Military Medicine pointed out that changes in healthcare have been... View Article

Diabetes

NPs, PAs Have as Good Diabetes Outcomes as Physicians

DURHAM, NC—So-called physician extenders do as good a job as physicians at the VA in helping to achieve good outcomes in diabetes patients, according to a new study. The report in Annals of Internal Medicine... View Article

Diabetes

Veterans on Standard Diabetes Care Face Dangers from Hypoglycemia Subhead: Post-hoc VADT Analysis Links Low Blood Sugar to CV Events

BALTIMORE, MD—A post-hoc analysis of the Veterans Affairs Diabetes Trial (VADT) once again shines a spotlight on the dangers of hypoglycemia in veterans treated for Type 2 diabetes. The study published in Diabetes Care found... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up